カテゴリー： 世界, 医療/バイオ, Market Monitor Global

多発がん検出血液検査のグローバル市場展望 2023年-2029年：ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他

【英語タイトル】Multi-Cancer Detection Blood Test Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23DC16197）・商品コード：MMG23DC16197
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年12月（※2025年版があります。お問い合わせください。）
・ページ数：79
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の多発がん検出血液検査市場規模と予測を収録しています。・世界の多発がん検出血液検査市場：売上、2018年-2023年、2024年-2029年
・世界の多発がん検出血液検査市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の多発がん検出血液検査市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ctDNA検査」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

多発がん検出血液検査のグローバル主要企業は、Galleri、 Amadix、 Burning Rock、 Exact Sciences、 Freenome、 AnchorDx、 Guardant Health、 Foundation Medicine、 GENECAST、 Coyne Medical、 Laboratory for Advanced Medicine、 Singlera Genomicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、多発がん検出血液検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の多発がん検出血液検査市場：タイプ別、2018年-2023年、2024年-2029年
世界の多発がん検出血液検査市場：タイプ別市場シェア、2022年
・ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他

世界の多発がん検出血液検査市場：用途別、2018年-2023年、2024年-2029年
世界の多発がん検出血液検査市場：用途別市場シェア、2022年
・病院、検査機関、その他

世界の多発がん検出血液検査市場：地域・国別、2018年-2023年、2024年-2029年
世界の多発がん検出血液検査市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における多発がん検出血液検査のグローバル売上、2018年-2023年
・主要企業における多発がん検出血液検査のグローバル売上シェア、2022年
・主要企業における多発がん検出血液検査のグローバル販売量、2018年-2023年
・主要企業における多発がん検出血液検査のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Galleri、 Amadix、 Burning Rock、 Exact Sciences、 Freenome、 AnchorDx、 Guardant Health、 Foundation Medicine、 GENECAST、 Coyne Medical、 Laboratory for Advanced Medicine、 Singlera Genomics

*************************************************************

・調査・分析レポートの概要
多発がん検出血液検査市場の定義
市場セグメント
世界の多発がん検出血液検査市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の多発がん検出血液検査市場規模
世界の多発がん検出血液検査市場規模：2022年 VS 2029年
世界の多発がん検出血液検査市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの多発がん検出血液検査の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の多発がん検出血液検査製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他
多発がん検出血液検査のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、検査機関、その他
多発がん検出血液検査の用途別グローバル売上・予測

・地域別市場分析
地域別多発がん検出血液検査市場規模 2022年と2029年
地域別多発がん検出血液検査売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Galleri、 Amadix、 Burning Rock、 Exact Sciences、 Freenome、 AnchorDx、 Guardant Health、 Foundation Medicine、 GENECAST、 Coyne Medical、 Laboratory for Advanced Medicine、 Singlera Genomics
...

This research report provides a comprehensive analysis of the Multi-Cancer Detection Blood Test market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Multi-Cancer Detection Blood Test market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Multi-Cancer Detection Blood Test, challenges faced by the industry, and potential opportunities for market players.
The global Multi-Cancer Detection Blood Test market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Multi-Cancer Detection Blood Test market presents opportunities for various stakeholders, including Hospitals, Diagnostic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Multi-Cancer Detection Blood Test market. Additionally, the growing consumer demand present avenues for market expansion.
The global Multi-Cancer Detection Blood Test market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Multi-Cancer Detection Blood Test market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Multi-Cancer Detection Blood Test market.
Market Overview: The report provides a comprehensive overview of the Multi-Cancer Detection Blood Test market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., ctDNA-Based Tests, Protein Biomarker-Based Tests), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Multi-Cancer Detection Blood Test market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Multi-Cancer Detection Blood Test market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Multi-Cancer Detection Blood Test market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Multi-Cancer Detection Blood Test market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Multi-Cancer Detection Blood Test market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Multi-Cancer Detection Blood Test market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Multi-Cancer Detection Blood Test, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Multi-Cancer Detection Blood Test market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Multi-Cancer Detection Blood Test market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others
Market segment by Application
Hospitals
Diagnostic Laboratories
Others
Global Multi-Cancer Detection Blood Test Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multi-Cancer Detection Blood Test, market overview.
Chapter 2: Global Multi-Cancer Detection Blood Test market size in revenue and volume.
Chapter 3: Detailed analysis of Multi-Cancer Detection Blood Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multi-Cancer Detection Blood Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Multi-Cancer Detection Blood Test capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Multi-Cancer Detection Blood Test Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multi-Cancer Detection Blood Test Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multi-Cancer Detection Blood Test Overall Market Size
2.1 Global Multi-Cancer Detection Blood Test Market Size: 2022 VS 2029
2.2 Global Multi-Cancer Detection Blood Test Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Multi-Cancer Detection Blood Test Sales: 2018-2029
3 Company Landscape
3.1 Top Multi-Cancer Detection Blood Test Players in Global Market
3.2 Top Global Multi-Cancer Detection Blood Test Companies Ranked by Revenue
3.3 Global Multi-Cancer Detection Blood Test Revenue by Companies
3.4 Global Multi-Cancer Detection Blood Test Sales by Companies
3.5 Global Multi-Cancer Detection Blood Test Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Multi-Cancer Detection Blood Test Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Multi-Cancer Detection Blood Test Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multi-Cancer Detection Blood Test Players in Global Market
3.8.1 List of Global Tier 1 Multi-Cancer Detection Blood Test Companies
3.8.2 List of Global Tier 2 and Tier 3 Multi-Cancer Detection Blood Test Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Multi-Cancer Detection Blood Test Market Size Markets, 2022 & 2029
4.1.2 ctDNA-Based Tests
4.1.3 Protein Biomarker-Based Tests
4.1.4 Methylation-Based Tests
4.1.5 Others
4.2 By Type – Global Multi-Cancer Detection Blood Test Revenue & Forecasts
4.2.1 By Type – Global Multi-Cancer Detection Blood Test Revenue, 2018-2023
4.2.2 By Type – Global Multi-Cancer Detection Blood Test Revenue, 2024-2029
4.2.3 By Type – Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
4.3 By Type – Global Multi-Cancer Detection Blood Test Sales & Forecasts
4.3.1 By Type – Global Multi-Cancer Detection Blood Test Sales, 2018-2023
4.3.2 By Type – Global Multi-Cancer Detection Blood Test Sales, 2024-2029
4.3.3 By Type – Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
4.4 By Type – Global Multi-Cancer Detection Blood Test Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Multi-Cancer Detection Blood Test Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application – Global Multi-Cancer Detection Blood Test Revenue & Forecasts
5.2.1 By Application – Global Multi-Cancer Detection Blood Test Revenue, 2018-2023
5.2.2 By Application – Global Multi-Cancer Detection Blood Test Revenue, 2024-2029
5.2.3 By Application – Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
5.3 By Application – Global Multi-Cancer Detection Blood Test Sales & Forecasts
5.3.1 By Application – Global Multi-Cancer Detection Blood Test Sales, 2018-2023
5.3.2 By Application – Global Multi-Cancer Detection Blood Test Sales, 2024-2029
5.3.3 By Application – Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
5.4 By Application – Global Multi-Cancer Detection Blood Test Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Multi-Cancer Detection Blood Test Market Size, 2022 & 2029
6.2 By Region – Global Multi-Cancer Detection Blood Test Revenue & Forecasts
6.2.1 By Region – Global Multi-Cancer Detection Blood Test Revenue, 2018-2023
6.2.2 By Region – Global Multi-Cancer Detection Blood Test Revenue, 2024-2029
6.2.3 By Region – Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
6.3 By Region – Global Multi-Cancer Detection Blood Test Sales & Forecasts
6.3.1 By Region – Global Multi-Cancer Detection Blood Test Sales, 2018-2023
6.3.2 By Region – Global Multi-Cancer Detection Blood Test Sales, 2024-2029
6.3.3 By Region – Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.4.2 By Country – North America Multi-Cancer Detection Blood Test Sales, 2018-2029
6.4.3 US Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.4.4 Canada Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.4.5 Mexico Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.5.2 By Country – Europe Multi-Cancer Detection Blood Test Sales, 2018-2029
6.5.3 Germany Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.4 France Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.5 U.K. Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.6 Italy Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.7 Russia Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.8 Nordic Countries Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.5.9 Benelux Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.6.2 By Region – Asia Multi-Cancer Detection Blood Test Sales, 2018-2029
6.6.3 China Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.4 Japan Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.5 South Korea Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.6 Southeast Asia Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.6.7 India Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.7.2 By Country – South America Multi-Cancer Detection Blood Test Sales, 2018-2029
6.7.3 Brazil Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.7.4 Argentina Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Multi-Cancer Detection Blood Test Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Multi-Cancer Detection Blood Test Sales, 2018-2029
6.8.3 Turkey Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8.4 Israel Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8.5 Saudi Arabia Multi-Cancer Detection Blood Test Market Size, 2018-2029
6.8.6 UAE Multi-Cancer Detection Blood Test Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Galleri
7.1.1 Galleri Company Summary
7.1.2 Galleri Business Overview
7.1.3 Galleri Multi-Cancer Detection Blood Test Major Product Offerings
7.1.4 Galleri Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.1.5 Galleri Key News & Latest Developments
7.2 Amadix
7.2.1 Amadix Company Summary
7.2.2 Amadix Business Overview
7.2.3 Amadix Multi-Cancer Detection Blood Test Major Product Offerings
7.2.4 Amadix Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.2.5 Amadix Key News & Latest Developments
7.3 Burning Rock
7.3.1 Burning Rock Company Summary
7.3.2 Burning Rock Business Overview
7.3.3 Burning Rock Multi-Cancer Detection Blood Test Major Product Offerings
7.3.4 Burning Rock Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.3.5 Burning Rock Key News & Latest Developments
7.4 Exact Sciences
7.4.1 Exact Sciences Company Summary
7.4.2 Exact Sciences Business Overview
7.4.3 Exact Sciences Multi-Cancer Detection Blood Test Major Product Offerings
7.4.4 Exact Sciences Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.4.5 Exact Sciences Key News & Latest Developments
7.5 Freenome
7.5.1 Freenome Company Summary
7.5.2 Freenome Business Overview
7.5.3 Freenome Multi-Cancer Detection Blood Test Major Product Offerings
7.5.4 Freenome Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.5.5 Freenome Key News & Latest Developments
7.6 AnchorDx
7.6.1 AnchorDx Company Summary
7.6.2 AnchorDx Business Overview
7.6.3 AnchorDx Multi-Cancer Detection Blood Test Major Product Offerings
7.6.4 AnchorDx Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.6.5 AnchorDx Key News & Latest Developments
7.7 Guardant Health
7.7.1 Guardant Health Company Summary
7.7.2 Guardant Health Business Overview
7.7.3 Guardant Health Multi-Cancer Detection Blood Test Major Product Offerings
7.7.4 Guardant Health Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.7.5 Guardant Health Key News & Latest Developments
7.8 Foundation Medicine
7.8.1 Foundation Medicine Company Summary
7.8.2 Foundation Medicine Business Overview
7.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Major Product Offerings
7.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.8.5 Foundation Medicine Key News & Latest Developments
7.9 GENECAST
7.9.1 GENECAST Company Summary
7.9.2 GENECAST Business Overview
7.9.3 GENECAST Multi-Cancer Detection Blood Test Major Product Offerings
7.9.4 GENECAST Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.9.5 GENECAST Key News & Latest Developments
7.10 Coyne Medical
7.10.1 Coyne Medical Company Summary
7.10.2 Coyne Medical Business Overview
7.10.3 Coyne Medical Multi-Cancer Detection Blood Test Major Product Offerings
7.10.4 Coyne Medical Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.10.5 Coyne Medical Key News & Latest Developments
7.11 Laboratory for Advanced Medicine
7.11.1 Laboratory for Advanced Medicine Company Summary
7.11.2 Laboratory for Advanced Medicine Business Overview
7.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Major Product Offerings
7.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.11.5 Laboratory for Advanced Medicine Key News & Latest Developments
7.12 Singlera Genomics
7.12.1 Singlera Genomics Company Summary
7.12.2 Singlera Genomics Business Overview
7.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Major Product Offerings
7.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Sales and Revenue in Global (2018-2023)
7.12.5 Singlera Genomics Key News & Latest Developments
8 Global Multi-Cancer Detection Blood Test Production Capacity, Analysis
8.1 Global Multi-Cancer Detection Blood Test Production Capacity, 2018-2029
8.2 Multi-Cancer Detection Blood Test Production Capacity of Key Manufacturers in Global Market
8.3 Global Multi-Cancer Detection Blood Test Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multi-Cancer Detection Blood Test Supply Chain Analysis
10.1 Multi-Cancer Detection Blood Test Industry Value Chain
10.2 Multi-Cancer Detection Blood Test Upstream Market
10.3 Multi-Cancer Detection Blood Test Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multi-Cancer Detection Blood Test Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Multi-Cancer Detection Blood Test in Global Market
Table 2. Top Multi-Cancer Detection Blood Test Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Multi-Cancer Detection Blood Test Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Multi-Cancer Detection Blood Test Revenue Share by Companies, 2018-2023
Table 5. Global Multi-Cancer Detection Blood Test Sales by Companies, (K Units), 2018-2023
Table 6. Global Multi-Cancer Detection Blood Test Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Multi-Cancer Detection Blood Test Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Multi-Cancer Detection Blood Test Product Type
Table 9. List of Global Tier 1 Multi-Cancer Detection Blood Test Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multi-Cancer Detection Blood Test Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Multi-Cancer Detection Blood Test Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Multi-Cancer Detection Blood Test Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Multi-Cancer Detection Blood Test Sales (K Units), 2018-2023
Table 15. By Type - Global Multi-Cancer Detection Blood Test Sales (K Units), 2024-2029
Table 16. By Application – Global Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Multi-Cancer Detection Blood Test Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Multi-Cancer Detection Blood Test Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Multi-Cancer Detection Blood Test Sales (K Units), 2018-2023
Table 20. By Application - Global Multi-Cancer Detection Blood Test Sales (K Units), 2024-2029
Table 21. By Region – Global Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Multi-Cancer Detection Blood Test Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Multi-Cancer Detection Blood Test Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Multi-Cancer Detection Blood Test Sales (K Units), 2018-2023
Table 25. By Region - Global Multi-Cancer Detection Blood Test Sales (K Units), 2024-2029
Table 26. By Country - North America Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Multi-Cancer Detection Blood Test Sales, (K Units), 2018-2023
Table 29. By Country - North America Multi-Cancer Detection Blood Test Sales, (K Units), 2024-2029
Table 30. By Country - Europe Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Multi-Cancer Detection Blood Test Sales, (K Units), 2018-2023
Table 33. By Country - Europe Multi-Cancer Detection Blood Test Sales, (K Units), 2024-2029
Table 34. By Region - Asia Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Multi-Cancer Detection Blood Test Sales, (K Units), 2018-2023
Table 37. By Region - Asia Multi-Cancer Detection Blood Test Sales, (K Units), 2024-2029
Table 38. By Country - South America Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Multi-Cancer Detection Blood Test Sales, (K Units), 2018-2023
Table 41. By Country - South America Multi-Cancer Detection Blood Test Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Multi-Cancer Detection Blood Test Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Multi-Cancer Detection Blood Test Sales, (K Units), 2024-2029
Table 46. Galleri Company Summary
Table 47. Galleri Multi-Cancer Detection Blood Test Product Offerings
Table 48. Galleri Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Galleri Key News & Latest Developments
Table 50. Amadix Company Summary
Table 51. Amadix Multi-Cancer Detection Blood Test Product Offerings
Table 52. Amadix Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Amadix Key News & Latest Developments
Table 54. Burning Rock Company Summary
Table 55. Burning Rock Multi-Cancer Detection Blood Test Product Offerings
Table 56. Burning Rock Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Burning Rock Key News & Latest Developments
Table 58. Exact Sciences Company Summary
Table 59. Exact Sciences Multi-Cancer Detection Blood Test Product Offerings
Table 60. Exact Sciences Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Exact Sciences Key News & Latest Developments
Table 62. Freenome Company Summary
Table 63. Freenome Multi-Cancer Detection Blood Test Product Offerings
Table 64. Freenome Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Freenome Key News & Latest Developments
Table 66. AnchorDx Company Summary
Table 67. AnchorDx Multi-Cancer Detection Blood Test Product Offerings
Table 68. AnchorDx Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. AnchorDx Key News & Latest Developments
Table 70. Guardant Health Company Summary
Table 71. Guardant Health Multi-Cancer Detection Blood Test Product Offerings
Table 72. Guardant Health Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Guardant Health Key News & Latest Developments
Table 74. Foundation Medicine Company Summary
Table 75. Foundation Medicine Multi-Cancer Detection Blood Test Product Offerings
Table 76. Foundation Medicine Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Foundation Medicine Key News & Latest Developments
Table 78. GENECAST Company Summary
Table 79. GENECAST Multi-Cancer Detection Blood Test Product Offerings
Table 80. GENECAST Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. GENECAST Key News & Latest Developments
Table 82. Coyne Medical Company Summary
Table 83. Coyne Medical Multi-Cancer Detection Blood Test Product Offerings
Table 84. Coyne Medical Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Coyne Medical Key News & Latest Developments
Table 86. Laboratory for Advanced Medicine Company Summary
Table 87. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product Offerings
Table 88. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Laboratory for Advanced Medicine Key News & Latest Developments
Table 90. Singlera Genomics Company Summary
Table 91. Singlera Genomics Multi-Cancer Detection Blood Test Product Offerings
Table 92. Singlera Genomics Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Singlera Genomics Key News & Latest Developments
Table 94. Multi-Cancer Detection Blood Test Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Multi-Cancer Detection Blood Test Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Multi-Cancer Detection Blood Test Production by Region, 2018-2023 (K Units)
Table 97. Global Multi-Cancer Detection Blood Test Production by Region, 2024-2029 (K Units)
Table 98. Multi-Cancer Detection Blood Test Market Opportunities & Trends in Global Market
Table 99. Multi-Cancer Detection Blood Test Market Drivers in Global Market
Table 100. Multi-Cancer Detection Blood Test Market Restraints in Global Market
Table 101. Multi-Cancer Detection Blood Test Raw Materials
Table 102. Multi-Cancer Detection Blood Test Raw Materials Suppliers in Global Market
Table 103. Typical Multi-Cancer Detection Blood Test Downstream
Table 104. Multi-Cancer Detection Blood Test Downstream Clients in Global Market
Table 105. Multi-Cancer Detection Blood Test Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Multi-Cancer Detection Blood Test Segment by Type in 2022
Figure 2. Multi-Cancer Detection Blood Test Segment by Application in 2022
Figure 3. Global Multi-Cancer Detection Blood Test Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Multi-Cancer Detection Blood Test Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Multi-Cancer Detection Blood Test Revenue, 2018-2029 (US$, Mn)
Figure 7. Multi-Cancer Detection Blood Test Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Multi-Cancer Detection Blood Test Revenue in 2022
Figure 9. By Type - Global Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 11. By Type - Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 12. By Type - Global Multi-Cancer Detection Blood Test Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 15. By Application - Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 16. By Application - Global Multi-Cancer Detection Blood Test Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 20. By Region - Global Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 21. By Country - North America Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 22. By Country - North America Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 23. US Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 28. Germany Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 29. France Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 37. China Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 41. India Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 43. By Country - South America Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 44. Brazil Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Multi-Cancer Detection Blood Test Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Multi-Cancer Detection Blood Test Sales Market Share, 2018-2029
Figure 48. Turkey Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Multi-Cancer Detection Blood Test Revenue, (US$, Mn), 2018-2029
Figure 52. Global Multi-Cancer Detection Blood Test Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Multi-Cancer Detection Blood Test by Region, 2022 VS 2029
Figure 54. Multi-Cancer Detection Blood Test Industry Value Chain
Figure 55. Marketing Channels

※参考情報

多発がん検出血液検査（Multi-Cancer Detection Blood Test）は、主に血液中の特定のバイオマーカーを用いて多種類のがんを早期に検出するための新しい技術です。この検査の概念は、がんによる死亡率を低下させるための早期発見に特化しており、従来の検査法とは異なる新しいアプローチを提供します。

まず、多発がん検出血液検査の定義について考えてみましょう。一般に、この検査は、血液サンプルを分析して体内に存在する可能性のある複数のがんを同時に検出する技術を指します。具体的には、血中に存在する特異的なDNA、RNA、タンパク質、またはその他のバイオマーカーを対象とします。このようなバイオマーカーは、腫瘍から放出されるものであり、がんが存在する場合に特有の情報を提供します。

次に、この検査の特徴について見ていきましょう。多発がん検出血液検査は、従来のがん検査と比較して、以下のようないくつかの重要な特徴を有しています。第一に、多くの異なるタイプのがんを同時に検出できるという点です。これは、早期段階でがんを発見するための重要な要素となります。また、非侵襲的な検査であるため、患者に対する負担が少なく、簡便に実施できるのも大きな利点です。さらに、定期的な健康診断の一環として容易に取り入れることができ、幅広い年齢層の人々に対して適用可能です。

次に、多発がん検出血液検査の種類について考えてみます。現在のところ、市場にはいくつかの異なるタイプの多発がん検出血液検査が存在しています。例えば、循環腫瘍DNA（ctDNA）を利用する検査や、エクソソームを対象とする検査、または特異的なタンパク質マーカーを測定する方法などがあります。これらの検査のいずれも、特定のがんに関連する分子を標的とし、それに基づいて診断を行います。

用途としては、まずがんの早期発見が挙げられます。がんは進行するにつれて治療が難しくなるため、早期発見が非常に重要です。多発がん検出血液検査は、症状が現れる前の段階でがんを検出することを目的としており、これにより患者の生存率を向上させることが期待されます。また、治療効果のモニタリングや再発の検出にも使用されることがあり、患者の状態の把握に寄与します。

関連技術についても考慮する必要があります。多発がん検出血液検査は、ゲノム解析技術や、高度なデータ解析アルゴリズムを用いることが一般的です。特に機械学習や人工知能（AI）が厳密なデータ解析において重要な役割を果たしています。これにより、検査結果の解釈をより正確に行うことが可能になっています。また、次世代シーケンシング（NGS）などの技術を組み合わせることで、より多くのバイオマーカーを網羅的に解析することができ、がんの検出精度を向上させることができます。

さらに、多発がん検出血液検査は研究の段階から臨床試験へと進展しており、その信頼性と有効性が検証されています。しかし、現在も技術の発展が続いているため、今後さらなる革新が期待されます。例えば、がんの特性に基づいた個別化医療との連携が進むことで、診断だけでなく治療法の選択にも利用可能となるかもしれません。

最後に、多発がん検出血液検査の普及に向けた課題について触れておきます。この技術はまだ比較的新しいため、医師とのコミュニケーションや、患者への説明責任も含めた適切な導入が求められます。また、保険適用やコストの課題も存在します。これらの問題を解決するためには、医療界の協力が不可欠であり、さらなる研究と開発が必要です。

まとめると、多発がん検出血液検査は複数のがんを早期に検出するための新しいアプローチであり、その利点は数多く存在します。今後の技術革新や研究の進展により、より多くの人々がこの検査の恩恵を受けられることが期待されています。様々な側面からの検討と取り組みが、がんの早期発見と治療の未来を切り開いていくことでしょう。


★調査レポート[多発がん検出血液検査のグローバル市場展望 2023年-2029年：ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他] (コード：MMG23DC16197)販売に関する免責事項を必ずご確認ください。
★調査レポート[多発がん検出血液検査のグローバル市場展望 2023年-2029年：ctDNA検査、タンパク質バイオマーカー検査、メチル化検査、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • フェリチンFIA検査キットのグローバル市場展望 2023年-2029年：診断用フェリチンFIA検査、研究用フェリチンFIA検査
  • 猫用ジステンパー抗原コロイド金迅速検出カードのグローバル市場展望 2023年-2029年：サンプル検査25部、サンプル検査50部
  • ブルセラ症検出キットのグローバル市場展望 2023年-2029年：ブルセラ間接ELISA抗体検出キット、ブルセラ競合ELISA抗体検出キット
  • 子供存在検知レーダーセンサーのグローバル市場展望 2023年-2029年：60GHz、77GHz

    • ◆H&Iグローバルリサーチのお客様（例）◆